Finance

Lists
Q4 2026 earnings • released • EPS miss -0.02% • Revenue beat +6.56%
See results
APD:NYSE
Air Products and Chemicals Inc
$304.84
-1.50%
(-4.65) 1D
$304.84
0.00% (0.00)
After hours
Closed: Nov 6, 4:00:03 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for APD...
Open
$302.36
High
$309.41
Low
$301.16
Mkt. cap
67.88B
Avg. vol.
1.07M
Volume
1.08M
Dividend
2.38%
Quarterly dividend
$1.81
Ex-dividend date
Oct 1, 2026
P/E ratio
127.70
52-wk high
$324.00
52-wk low
$229.11
EPS
$2.39
Beta
0.67
Shares outstanding
222.69M
No. of employees
21K
Open
$302.36
High
$309.41
Low
$301.16
Mkt. cap
67.88B
Avg. vol.
1.07M
Volume
1.08M
Dividend
2.38%
Quarterly dividend
$1.81
Ex-dividend date
Oct 1, 2026
P/E ratio
127.70
52-wk high
$324.00
52-wk low
$229.11
EPS
$2.39
Beta
0.67
Shares outstanding
222.69M
No. of employees
21K
News stories
From web sources and news partners
Profile
Air Products and Chemicals, Inc. is a U.S.-based international corporation whose principal business is selling gases and chemicals for industrial use. Air Products is headquartered in Trexlertown, Pennsylvania, in the Lehigh Valley region of eastern Pennsylvania. As of 2024, Air Products is the fifth-largest employer in the Lehigh Valley. Wikipedia
About Air Products and Chemicals Inc
CEOEduardo Menezes
Employees21.2K
Founded1940
HeadquartersAllentown, Pennsylvania, United States
SectorMaterials
IndustryIndustrial gas
Websiteairproducts.com
Analyst ratings
Based on 12 analysts giving stock ratings to APD in the past 3 months
Buy
Buy
7
Hold
5
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for APD in the last 3 months.
Highest
Current $304.84
$373.00 (+22.36%)
Average
$341.36 (+11.98%)
Lowest
$312.00 (+2.35%)
Analyst
Recommendation
Action
Price target
Projected
Date
John McNulty
BMO Capital
Buy
Reiterated
$362.00
+18.8%
11/06/2026
Joshua Spector
UBS
Hold
Maintained
$330.00
+8.3%
11/06/2026
Arun Viswanathan
RBC Capital
Buy
Maintained
$359.00
+17.8%
11/05/2026
John Roberts CFA
Mizuho Securities
Buy
Maintained
$360.00
+18.1%
11/06/2026
Aleksey Yefremov
Barclays
Buy
Maintained
$346.00
+13.5%
11/06/2026
James Hooper
Bernstein
Buy
Reiterated
$373.00
+22.4%
10/26/2026
Abigail Eberts
Wells Fargo
Buy
Reiterated
$350.00
+14.8%
10/16/2026
Matthew DeYoe
Bank of America Securities
Hold
Maintained
$314.00
+3%
10/12/2026
Michael Leithead
Barclays
Buy
Initiated
$353.00
+15.8%
10/12/2026
Patrick Cunningham
Citi
Hold
Maintained
$312.00
+2.3%
10/08/2026
Unknown Analyst
KeyBanc
Hold
Initiated
-
-
09/11/2026
Salvator Tiano
KeyBanc
Hold
Initiated
-
-
09/11/2026
Alexandra Yates
Argus Research
Buy
Maintained
$329.00
+7.9%
09/08/2026
David Begleiter
Deutsche Bank
Hold
Maintained
$320.00
+5%
09/08/2026
Vincent Andrews
Morgan Stanley
Hold
Reiterated
$320.00
+5%
08/03/2026
Jeffrey Zekauskas
J.P. Morgan
Buy
Maintained
$330.00
+8.3%
07/31/2026
Unknown Analyst
Seaport Global
Hold
Maintained
-
-
07/30/2026
Unknown Analyst
Jefferies
Buy
Maintained
$351.00
+15.1%
07/31/2026
Duffy Fischer
Goldman Sachs
Buy
Maintained
$360.00
+18.1%
07/30/2026
Peter Clark
Bernstein
Buy
Maintained
$345.00
+13.2%
07/17/2026
Eric Boyes
Evercore ISI
Buy
Maintained
$342.00
+12.2%
07/10/2026
Michael Sison
Wells Fargo
Buy
Reiterated
$340.00
+11.5%
05/26/2026
Hassan Ahmed
Alembic Global
Buy
Maintained
$345.00
+13.2%
04/30/2026
Sebastian Bray
Berenberg Bank
Buy
Upgraded
$350.00
+14.8%
04/17/2026
Unknown Analyst
Berenberg Bank
Buy
Upgraded
$350.00
+14.8%
04/17/2026
Bill Selesky
Argus Research
Buy
Maintained
$316.00
+3.7%
03/17/2026
Last report
Nov 5, 2026
Fiscal period
Q4 2026
$3.61 / $3.61
-0.02%miss
Revenue / Est. (USD)
3.56B / 3.34B
+6.56%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.17B
3.10B
3.17B
3.16B
Cost of goods sold
2.15B
2.11B
2.18B
2.12B
Cost of revenue
2.15B
2.11B
2.18B
2.12B
Research and development expenses
27.30M
20.40M
21.60M
21.50M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
231.20M
232.40M
230.80M
222.60M
Operating expense
222.00M
241.70M
239.00M
228.80M
Total operating expenses
2.37B
2.35B
2.42B
2.35B
Operating income
799.40M
753.30M
748.40M
807.20M
Other non operating income
11.00M
12.70M
29.10M
-5.70M
EBT including unusual items
121.30M
850.80M
883.50M
-1.94B
EBT excluding unusual items
917.20M
872.80M
884.80M
969.70M
Income tax expense
111.20M
159.40M
158.70M
-515.40M
Effective tax rate
91.67%
18.74%
17.96%
26.60%
Other operating expenses
-36.50M
-11.10M
-13.40M
-15.30M
Net income
4.90M
678.20M
710.40M
-1.44B
Net profit margin
0.15%
21.86%
22.40%
-45.58%
Earnings per share
3.39
3.16
3.20
3.47
Interest and investment income
-
-
-
-
Interest expense
-68.00M
-52.60M
-49.50M
-49.40M
Net interest expenses
-68.00M
-52.60M
-49.50M
-49.40M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.21B
1.12B
1.12B
1.19B
Gain or loss from assets sale
-19.50M
-2.20M
-1.80M
-700.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps